Table 3.
Effects of Total Sleep Score on CHR Symptom Domain
| Symptom Domain | Main Effect (Total Sleep Over Time) | Group Effect | Sleep-by-Group Interaction | ||||
|---|---|---|---|---|---|---|---|
| B (95% CIs) | P | Group | B (95% CIs) | P | B (95% CIs) | P | |
| SOPS total | |||||||
| 0.56 (0.45, 0.67) | <.001 | Controls CHR-NC CHR-C |
-
28.98 (26.56, 31.41) 36.5 (33.14, 39.87) |
-
<.001 <.001 |
−0.27 (−0.09, 0.63) −0.16 (−0.62, 0.30) |
− 15 .49 |
|
| Positive symptoms | |||||||
| 0.11 (0.07, 0.15) | <.001 | Controls CHR-NC CHR-C |
-
10.87 (10.18, 11.56) 12.42 (11.46, 13.38) |
-
<.001 <.001 |
− 0.06 (−0.06, 0.19) 0.04 (−0.12, 0.20) |
− .32 .61 |
|
| Negative symptoms | |||||||
| 0.20 (0.15, 0.25) | <.001 | Controls CHR-NC CHR-C |
-
8.79 (7.61, 9.97) 12.16 (10.51, 13.8) |
− <.001 <.001 |
− 0.1 (−0.08, 0.27) −0.18 (−0.40, 0.04) |
− .27 .12 |
|
| Disorganized symptoms | |||||||
| 0.08 (0.06, 0.11) | <.001 | Controls CHR-NC CHR-C |
-
3.74 (3.13, 4.36) 5.94 (5.08, 6.79) |
− <.001 <.001 |
− 0.06 (−0.03, 0.14) −0.02 (−0.14, 0.09) |
− .22 .69 |
|
| General symptoms | |||||||
| 0.22 (0.18, 0.25) | <.001 | Controls CHR-NC CHR-C |
− 4.69 (4.06, 5.31) 5.41 (4.54, 6.28) |
− <.001 <.001 |
− 0.08 (−0.03, 0.19) 0.01 (−0.13, 0.16) |
− .18 .84 |
|
Note: CHR-NC = Clinical High Risk Non-Converters; Bonferroni adjusted significant P-value ≤ .002; Controls were used as reference group.